Nomenclature
CAS number: 26629-87-8
4-(1-Methylethyl)-2-[3-(trifluoromethyl)phenyl]morpholine; 4-isopropyl-2-(α,α,α-trifluoro-
m-tolyl)morpholine; tetrahydro-4-isopropyl-2-[3-(trifluoromethyl)phenyl]-2
H-oxazine.
C
14H
18F
3NO; mol wt 273.29.
C 61.53%, H 6.64%, F 20.86%, N 5.13%, O 5.85%.
Description and references
Non-tricyclic antidepressant agent. Prepn:
R. Y. Mauvernay et al., FR 1564792; eidem, US 3637680 (1969, 1972 both to CERM); N. Busch et al., Eur. J. Med. Chem. - Chim. Ther. 11, 201 (1976). Improved synthesis: P. M. Weintraub et al., J. Org. Chem. 45, 4989 (1980). Pharmacological profile: J. Hache et al., Therapie 29, 81 (1974).
Urinary metabolism: M. Constantin, J. F. Pognat, Arzneim.-Forsch. 29, 109 (1979).
Preliminary clinical study: A. Rascol et al., Therapie 29, 95 (1974).
Properties
Oil, bp0.005 52°; bp3 99°. nD24 1.4751.Derivative
Hydrochloride.
Nomenclature
CAS number: 26629-86-7
CERM-1766; Conflictan (Riom).
C
14H
18F
3NO.HCl; mol wt 309.75.
C 54.29%, H 6.18%, F 18.40%, N 4.52%, O 5.17%, Cl 11.45%.
Properties
Crystals from ethyl acetate/ethanol, mp 164°. LD50 in mice (mg/kg): 365 orally, 90 i.v. (Mauvernay, 1969); also
reported as: 420 orally, 80 i.v. (Hache).Therapeutic Category
Antidepressant.
Keywords
Antidepressant
Status
This monograph has been retired and is no longer subject
to revision or update.